DRYGIN DENIS (Chief Scientific Officer) purchased 328.9% of their position (76.69K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market purchase worth $17.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/1/2022ACC: 0001209191-22-014248
Officer· Chief Scientific Officer
Since Aug 2020
+76.69K
Net shares
Net buyer
$17.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
76.69K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+76.69K
Price / share
$0.23
Trade value
$17.64K
% of position
328.9%
3/1/2022
23.31K→100K
Total
Net shares
+76.69K
Net value
$17.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2022 | P · Purchase | +76.69K | $0.23 | $17.64K | 328.9% | 23.31K | 100K |
| Total | +76.69K | $17.64K | ||||||
Derivative Transactions0
No derivative transactions reported